{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20211104",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "69266",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/210598Orig1s002ltr.pdf",
              "date": "20211105",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20181109",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "56398",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf",
              "date": "20181109",
              "type": "Label"
            },
            {
              "id": "56429",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/210598Orig1s000ltr.pdf",
              "date": "20181114",
              "type": "Letter"
            },
            {
              "id": "56752",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210598Orig1s000TOC.html",
              "date": "20181217",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20220525",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "71151",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/210598s003lbl.pdf",
              "date": "20220526",
              "type": "Label"
            },
            {
              "id": "71154",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/210598Orig1s003ltr.pdf",
              "date": "20220526",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190521",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "58827",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/210598Orig1s001ltr.pdf",
              "date": "20190522",
              "type": "Letter"
            },
            {
              "id": "58829",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210598s001lbl.pdf",
              "date": "20190522",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA210598",
      "sponsor_name": "MYLAN IRELAND LTD",
      "openfda": {
        "application_number": [
          "NDA210598"
        ],
        "brand_name": [
          "YUPELRI"
        ],
        "generic_name": [
          "REVEFENACIN"
        ],
        "manufacturer_name": [
          "Viatris Specialty LLC"
        ],
        "product_ndc": [
          "49502-806"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "RESPIRATORY (INHALATION)"
        ],
        "substance_name": [
          "REVEFENACIN"
        ],
        "rxcui": [
          "2102779",
          "2102784"
        ],
        "spl_id": [
          "b7b789a7-deb0-41d7-9c7d-e6cf68d1b893"
        ],
        "spl_set_id": [
          "6dfebf04-7c90-436a-9b16-750d3c1ee0a6"
        ],
        "package_ndc": [
          "49502-806-32",
          "49502-806-93",
          "49502-806-77",
          "49502-806-33",
          "49502-806-87"
        ],
        "nui": [
          "N0000175574",
          "N0000175370"
        ],
        "pharm_class_epc": [
          "Anticholinergic [EPC]"
        ],
        "pharm_class_moa": [
          "Cholinergic Antagonists [MoA]"
        ],
        "unii": [
          "G2AE2VE07O"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "YUPELRI",
          "active_ingredients": [
            {
              "name": "REVEFENACIN",
              "strength": "175MCG/3ML"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION",
          "route": "INHALATION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}